Most recently, KDM4C has been described as a regulator of stemness [26–29], cancer cell resistance [30, 31] and cancer progression [32, 33] in various cancer models and KDM4C germline variants may increase multi-cancer vulnerability through dysregulation of target histone methylation [34]. The gene discussed is KDM4C; the disease is cancer.